TY  - GEN
AU  - Hung,Man-Hsin
AU  - Wang,Cheng-Yi
AU  - Chen,Yen-Lin
AU  - Chu,Pei-Yi
AU  - Hsiao,Yung-Jen
AU  - Tai,Wei-Tien
AU  - Chao,Ting-Ting
AU  - Yu,Hui-Chuan
AU  - Shiau,Chung-Wai
AU  - Chen,Kuen-Feng
TI  - SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A
SN  - 1949-2553
PY  - 2016///1107
KW  - Aged
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - DNA-Binding Proteins
KW  - Disease-Free Survival
KW  - Drug Synergism
KW  - Enzyme Activation
KW  - Female
KW  - Histone Chaperones
KW  - antagonists & inhibitors
KW  - Humans
KW  - Immunohistochemistry
KW  - Lung Neoplasms
KW  - Male
KW  - Mice, Nude
KW  - Middle Aged
KW  - Paclitaxel
KW  - administration & dosage
KW  - Protein Phosphatase 2
KW  - metabolism
KW  - Proto-Oncogene Proteins c-akt
KW  - Quinazolines
KW  - RNA Interference
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Transcription Factors
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.6313
ER  -